A Comprehensive Literature Review on the Pandemic Coronavirus Disease 2019 (COVID-19): Bangladesh Is Fighting Against It

Umme Shahera, N. Sultana, Mahbuba Sharmin, Jayanta Malakar, M. Islam, Kazi Mohammed Zafrul Haq
{"title":"A Comprehensive Literature Review on the Pandemic Coronavirus Disease 2019 (COVID-19): Bangladesh Is Fighting Against It","authors":"Umme Shahera, N. Sultana, Mahbuba Sharmin, Jayanta Malakar, M. Islam, Kazi Mohammed Zafrul Haq","doi":"10.11648/j.ajbls.20200804.13","DOIUrl":null,"url":null,"abstract":"A large number of patient developed pneumonia of unknown cause in the capital city Wuhan of Hubei province in China during the month of Dec 2019, with clinical presentations greatly resembling viral pneumonia while some rapidly progressed to severe illness and fatal outcome. International Committee on Taxonomy of Viruses (ICTV) named the virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and WHO officially named the disease COVID-19. World Health Organization (WHO) on January 30 declared the outbreak as a public health emergency of international concern due to rapid global spread. On 11 February 2020, WHO announced that \"COVID-19\" (meaning coronavirus disease-2019) will be the official name of the disease. This report reviews the genetic structure, infection source, transmission route, pathogenesis, clinical characteristics, and treatment and prevention of the SARS-CoV-2, so that it can provide references for follow-up research, prevention and treatment, and may help readers to have the latest understanding of this new infectious disease. Information have been gathered mainly from relevant researches and papers that were published recently. For this narrative review, more than 49 relevant scientific articles and reports were considered from various databases (e.g., Google Scholar, PubMed and Science Direct) using keywords such as SARS-CoV-2; COVID-19; corona virus; pneumonia; respiratory infection. The results from this review show that the situation is rapidly evolving, as human-to-human transmission is occurring, and the number of new cases and mortalities is increasing by the day and on a global level. There is still ambiguity about mutation risks and how the virus spreads as the source was not yet identified. Major gaps in knowledge about the origin of the virus, epidemiology and transmission impose a great challenge, which emphasizes the need for further studies in the future. There are neither vaccines nor effective treatments for the disease caused by the virus, but efforts are typically confined to symptomatic and supportive management. Antiviral and corticosteroids were used in severe illness but had no effective outcome.","PeriodicalId":7857,"journal":{"name":"American Journal of Biomedical and Life Sciences","volume":"36 1","pages":"76"},"PeriodicalIF":0.0000,"publicationDate":"2020-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Biomedical and Life Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11648/j.ajbls.20200804.13","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4

Abstract

A large number of patient developed pneumonia of unknown cause in the capital city Wuhan of Hubei province in China during the month of Dec 2019, with clinical presentations greatly resembling viral pneumonia while some rapidly progressed to severe illness and fatal outcome. International Committee on Taxonomy of Viruses (ICTV) named the virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and WHO officially named the disease COVID-19. World Health Organization (WHO) on January 30 declared the outbreak as a public health emergency of international concern due to rapid global spread. On 11 February 2020, WHO announced that "COVID-19" (meaning coronavirus disease-2019) will be the official name of the disease. This report reviews the genetic structure, infection source, transmission route, pathogenesis, clinical characteristics, and treatment and prevention of the SARS-CoV-2, so that it can provide references for follow-up research, prevention and treatment, and may help readers to have the latest understanding of this new infectious disease. Information have been gathered mainly from relevant researches and papers that were published recently. For this narrative review, more than 49 relevant scientific articles and reports were considered from various databases (e.g., Google Scholar, PubMed and Science Direct) using keywords such as SARS-CoV-2; COVID-19; corona virus; pneumonia; respiratory infection. The results from this review show that the situation is rapidly evolving, as human-to-human transmission is occurring, and the number of new cases and mortalities is increasing by the day and on a global level. There is still ambiguity about mutation risks and how the virus spreads as the source was not yet identified. Major gaps in knowledge about the origin of the virus, epidemiology and transmission impose a great challenge, which emphasizes the need for further studies in the future. There are neither vaccines nor effective treatments for the disease caused by the virus, but efforts are typically confined to symptomatic and supportive management. Antiviral and corticosteroids were used in severe illness but had no effective outcome.
关于2019年冠状病毒大流行疾病(COVID-19)的综合文献综述:孟加拉国正在与之抗争
2019年12月,中国湖北省省会武汉市出现大量不明原因肺炎患者,临床表现与病毒性肺炎非常相似,部分患者病情迅速发展为重症并导致死亡。国际病毒分类委员会(ICTV)将该病毒命名为严重急性呼吸综合征冠状病毒2 (SARS-CoV-2),世卫组织将其正式命名为COVID-19。1月30日,世界卫生组织(WHO)宣布,由于疫情在全球迅速蔓延,此次疫情为国际关注的突发公共卫生事件。2020年2月11日,世卫组织宣布“COVID-19”(意为冠状病毒病-2019)将成为该疾病的正式名称。本文综述了SARS-CoV-2的遗传结构、感染源、传播途径、发病机制、临床特点、治疗和预防等方面的情况,为后续研究、预防和治疗提供参考,也有助于读者对这一新型传染病有最新的认识。资料主要来源于近期发表的相关研究和论文。在本次叙述性综述中,使用SARS-CoV-2等关键词,从各种数据库(例如Google Scholar、PubMed和Science Direct)中考虑了49多篇相关科学文章和报告;COVID-19;冠状病毒;肺炎;呼吸道感染。这次审查的结果表明,随着人与人之间的传播正在发生,情况正在迅速演变,新病例和死亡人数在全球范围内每天都在增加。由于来源尚未确定,关于突变风险和病毒如何传播仍然存在不确定性。关于该病毒的起源、流行病学和传播方面的知识存在重大差距,这是一个巨大的挑战,这强调了今后需要进一步研究。这种病毒引起的疾病既没有疫苗,也没有有效的治疗方法,但努力通常局限于对症和支持性管理。在重症患者中使用抗病毒药物和皮质类固醇,但没有有效的结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信